188 related articles for article (PubMed ID: 22263916)
1. Paroxetine for the treatment of depression: a critical update.
Gibiino S; Serretti A
Expert Opin Pharmacother; 2012 Feb; 13(3):421-31. PubMed ID: 22263916
[TBL] [Abstract][Full Text] [Related]
2. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Sanchez C; Reines EH; Montgomery SA
Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine use in medically ill patients.
Stout SS; Somerset WI; Miller A; Musselman DL
Psychopharmacol Bull; 2003; 37 Suppl 1():108-22. PubMed ID: 14566206
[TBL] [Abstract][Full Text] [Related]
4. Focus on paroxetine.
Green B
Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
[TBL] [Abstract][Full Text] [Related]
5. [Paroxetine (paxil): use in clinical practice].
Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
[No Abstract] [Full Text] [Related]
6. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
Li L; Han Z; Li L; Han L; Yan B
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine in the treatment of generalised anxiety disorder.
Snyderman SH; Rynn MA; Bellew K; Rickels K
Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
[TBL] [Abstract][Full Text] [Related]
8. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Strobel M; Warnke A; Roth M; Schulze U
Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
Gunasekara NS; Noble S; Benfield P
Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
[TBL] [Abstract][Full Text] [Related]
10. [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].
Mosolov SN; Kostiukova EG; Gorodnichev AV; Timofeev IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):22-9. PubMed ID: 16281375
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
Miskovic M
Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260
[TBL] [Abstract][Full Text] [Related]
12. Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs?
Komaroff AL
Harv Health Lett; 2012 Aug; 37(10):2. PubMed ID: 22991725
[No Abstract] [Full Text] [Related]
13. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA
J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
[TBL] [Abstract][Full Text] [Related]
14. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
[TBL] [Abstract][Full Text] [Related]
15. [Increased perioperative blood loss during treatment with paroxetine].
Sewnath ME; van Hillegersberg R; Koopman MM; Levi MM; Gouma DJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1800-2. PubMed ID: 12369443
[TBL] [Abstract][Full Text] [Related]
16. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
17. Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.
Appelhof BC; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Huyser J; Schene AH; Tijssen JG; Wiersinga WM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6271-6. PubMed ID: 15579788
[TBL] [Abstract][Full Text] [Related]
18. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
19. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
